RecruitingEarly Phase 1NCT06482762

Low-Intensity Focused Ultrasound of the Amygdala for Bipolar Disorder


Sponsor

Massachusetts General Hospital

Enrollment

20 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of transcranial focused ultrasound (tFUS) as a treatment for bipolar disorder (BD). Specifically, the investigators will study the effects of amygdala tFUS on corticolimbic activation during an emotion regulation task in BD, the effects of amygdala tFUS on corticolimbic resting-state functional connectivity in BD, and explore the relationship between tFUS-associated changes in amygdala activity and mood symptoms. The investigators hypothesize that transcranial focused ultrasound (tFUS) of the amygdala will be associated with decreased amygdala activation and increased ventromedial prefrontal cortex activation during a modified version of the Multi-Source Interference Task (MSIT) paired with affective pictures from the International Affective Picture System (IAPS). The investigators also hypothesize that tFUS of the amygdala will be associated with increased resting-state functional connectivity between the amygdala and ventromedial prefrontal cortex. Finally, the investigators hypothesize that tFUS-associated reductions in amygdala activity could be positively correlated with reductions in depressive symptom scores and global improvement.


Eligibility

Min Age: 18 YearsMax Age: 64 Years

Inclusion Criteria5

  • Primary diagnosis of BD (can be BD-I or BD-II)
  • Age 18-64
  • Normal or corrected-to normal vision and hearing
  • YMRS ≤ 12
  • BDI ≥ 14

Exclusion Criteria5

  • Active neurological disorder
  • Current psychosis symptoms
  • MRI scan contraindications (e.g., metal implant, claustrophobia, weigh over 250 pounds, etc.)
  • YMRS > 13
  • BDI < 14

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBrainSonix Pulsar 1002

Device that delivers low intensity focused ultrasound


Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06482762


Related Trials